Juzenkai The Sakakibara Heart Institute of Okayama

Okayama, Okayama 700-0804

2 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure, Hypertension

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now